A CDC research report documenting significant protective benefits from Covid vaccines has stalled under review by the agency's acting director, sparking alarm among public health officials about potential political interference.
The unreleased study, conducted by CDC scientists, found that Covid vaccination cut emergency room visits and hospitalizations for healthy adults by approximately 50 percent during last winter, according to the Washington Post. Jay Bhattacharya, a Trump administration appointee now leading the CDC, has blocked publication of the findings, citing methodological concerns about the research.
The delay has triggered concerns that the administration is employing subtle pressure to suppress vaccine efficacy data. Public health advocates worry the tactic signals a coordinated effort to undermine confidence in Covid immunizations as the new administration takes shape.
Bhattacharya has raised questions about the study's approach, though critics argue the scrutiny appears selective given similar work typically moves through CDC approval channels more quickly. The specific methodological issues he cited remain unclear, and the agency has not provided a timeline for completing its review.
The situation echoes broader tensions over scientific independence at federal health agencies. The Trump transition team has signaled plans to reshape health policy and vaccine guidance, raising questions about whether internal CDC reviews will remain insulated from political considerations.
CDC officials declined to comment on the status of the report or expected publication date. The vaccine benefits documented in the study represent among the clearest recent evidence of protection against severe Covid outcomes in a large population, making the publication delay potentially consequential for public health messaging heading into the respiratory illness season.
Comments